These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 33539432

  • 1. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry.
    Schafer A, Xiong R, Cooper L, Nowar R, Lee H, Li Y, Ramirez BE, Peet NP, Caffrey M, Thatcher GRJ, Saphire EO, Cheng H, Rong L.
    PLoS Pathog; 2021 Feb; 17(2):e1009312. PubMed ID: 33539432
    [Abstract] [Full Text] [Related]

  • 2. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Wirchnianski AS, Wec AZ, Nyakatura EK, Herbert AS, Slough MM, Kuehne AI, Mittler E, Jangra RK, Teruya J, Dye JM, Lai JR, Chandran K.
    Front Immunol; 2021 Feb; 12():729851. PubMed ID: 34721393
    [Abstract] [Full Text] [Related]

  • 3. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.
    J Infect Dis; 2015 Oct 01; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.
    J Virol; 2015 Oct 01; 89(19):9932-8. PubMed ID: 26202243
    [Abstract] [Full Text] [Related]

  • 5. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
    Lennemann NJ, Dillard J, Ruggio N, Cooney AL, Schaack GA, Davey RA, Maury W.
    J Virol; 2021 Aug 25; 95(18):e0107321. PubMed ID: 34232742
    [Abstract] [Full Text] [Related]

  • 6. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH, Wong AC, Grodus MG, Recht HS, Pulanco MC, Lasso G, Anthony SJ, Mittler E, Jangra RK, Chandran K.
    J Virol; 2020 Aug 31; 94(18):. PubMed ID: 32611759
    [Abstract] [Full Text] [Related]

  • 7. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE, Fénéant L, Szymańska-de Wijs KM, Kessler NP, Nelson EA, Shoemaker CJ, Schmaljohn CS, Polyak SJ, White JM.
    J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30700611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by In Situ Proximity Ligation.
    Mittler E, Alkutkar T, Jangra RK, Chandran K.
    mBio; 2021 Jan 12; 12(1):. PubMed ID: 33436438
    [Abstract] [Full Text] [Related]

  • 10. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
    Nelson EA, Dyall J, Hoenen T, Barnes AB, Zhou H, Liang JY, Michelotti J, Dewey WH, DeWald LE, Bennett RS, Morris PJ, Guha R, Klumpp-Thomas C, McKnight C, Chen YC, Xu X, Wang A, Hughes E, Martin S, Thomas C, Jahrling PB, Hensley LE, Olinger GG, White JM.
    PLoS Negl Trop Dis; 2017 Apr 12; 11(4):e0005540. PubMed ID: 28403145
    [Abstract] [Full Text] [Related]

  • 11. Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.
    Beck S, Henß L, Weidner T, Herrmann J, Müller R, Chao YK, Grimm C, Weber C, Sliva K, Schnierle BS.
    Antiviral Res; 2016 Aug 12; 132():85-91. PubMed ID: 27241689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M, Furuyama W, Kuroda M, Kondoh T, Igarashi M, Kajihara M, Yoshida R, Manzoor R, Okuya K, Miyamoto H, Feldmann H, Marzi A, Sakaitani M, Nanbo A, Takada A.
    Antiviral Res; 2020 Nov 12; 183():104932. PubMed ID: 32946918
    [Abstract] [Full Text] [Related]

  • 15. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y, Qiu S, Mulloy RP, Côté M.
    J Virol; 2020 Jul 30; 94(16):. PubMed ID: 32493822
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection.
    Ren J, Zhao Y, Fry EE, Stuart DI.
    J Med Chem; 2018 Feb 08; 61(3):724-733. PubMed ID: 29272110
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
    Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W.
    mBio; 2014 Jan 28; 5(1):e00862-13. PubMed ID: 24473128
    [Abstract] [Full Text] [Related]

  • 19. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections.
    Gaisina IN, Peet NP, Wong L, Schafer AM, Cheng H, Anantpadma M, Davey RA, Thatcher GRJ, Rong L.
    J Med Chem; 2020 Jul 09; 63(13):7211-7225. PubMed ID: 32490678
    [Abstract] [Full Text] [Related]

  • 20. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L.
    Antiviral Res; 2017 Sep 09; 145():24-32. PubMed ID: 28645623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.